Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 3:13:1945-1962.
doi: 10.2147/IJN.S153763. eCollection 2018.

In vitro/vivo drug release and anti-diabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles

Affiliations

In vitro/vivo drug release and anti-diabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles

Fei Tong et al. Int J Nanomedicine. .

Retraction in

Abstract

Background: The objective of this study was to survey the therapeutic function of curcumin-encapsulated poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly(gammabenzyl l-glutamate) (PBLG-PEG-PBLG) (P) on diabetic cardiomyopathy (DCM) via cross regulation effect of calcium-sensing receptor (CaSR) and endogenous cystathionine-γ-lyase (CSE)/hydrogen sulfide (H2S).

Methods: Diabetic rats were preconditioned with 20 mg/kg curcumin or curcumin/P complex continuously for 8 weeks. The blood and myocardiums were collected, the level of serum H2S was observed, and the [Ca2+]i content was measured in myocardial cells, and hematoxylin-eosin, CaSR, CSE, and calmodulin (CaM) expression were detected.

Results: Both curcumin and curcumin/P pretreatment alleviated pathological morphological damage of myocardium, increased H2S and [Ca2+]i levels, and upregulated the expression of CaSR, CSE, and CaM as compared to DCM group, while curcumin/P remarkably augmented this effect.

Conclusion: PBLG-PEG-PBLG could improve water-solubility and bioactivity of curcumin and curcumin/PBLG-PEG-PBLG significantly alleviated diabetic cardiomyopathy.

Keywords: CSE; CaSR; PBLG-PEG-PBLG; curcumin; diabetic cardiomyopathy.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this study.

Figures

Figure 1
Figure 1
The structure of PBLG-PEG-PBLG (P). Abbreviation: P, poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly (gamma-benzyl l-glutamate).
Figure 2
Figure 2
The TEM images of P and curcumin/P. Notes: (A) TEM of PBLG-PEG-PBLG; (B) TEM of curcumin/PBLG-PEG-PBLG. Abbreviations: TEM, transmission electron microscopy; P, poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl l-glutamate).
Figure 3
Figure 3
The cumulative releasing profile of free curcumin and curcumin from curcumin/P complexes and results are expressed as mean ± standard deviation. Abbreviation: P, poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly (gamma-benzyl l-glutamate).
Figure 4
Figure 4
Blood curcumin concentrations of curcumin and curcumin from curcumin/P complexes in rats and results are expressed as mean ± standard deviation. Abbreviation: P, poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly (gamma-benzyl l-glutamate).
Figure 5
Figure 5
(A) Histopathologic assessment of myocardial damage; (B) blood glucose, Chol, and TG levels; (C) serum insulin level. Notes: (A) Light microscope images (×100) in Sham group (a), DM-4w group (b), and DM-8w group (c). The quantitative analysis of histopathologic assessment is shown in “d”. Results are expressed as mean ± SD. A significant increase from Sham group is denoted by *p<0.01, and a significant increase from DW-4w group is denoted by **p<0.01. (B) The blood of Sham, DM-4w, and DM-8w groups were collected, and the levels of blood glucose, Chol, and TG were measured. Results are expressed as mean ± SD. A significant increase from Sham group is denoted by *p<0.01, and a significant increase from DW-4w group is denoted by **p<0.01. (C) The blood of Sham, DM-4w, and DM-8w groups were collected and the levels of serum insulin were measured. Results are expressed as mean ± SD. A significant increase from Sham group is denoted by *p<0.01, and a significant increase from DW-4w groups is denoted by **p<0.01. Abbreviations: DM, diabetes mellitus; Chol, cholesterol; TG, triglyceride; SD, standard deviation.
Figure 6
Figure 6
(A) CaSR expression in Sham, DM-4w, and DM-8w groups; (B) CSE expression in Sham, DM-4w, and DM-8w groups; (C) CaSR expression in Sham and DM-8w+CaRS groups; (D) CSE expression in Sham and DM-8w+CaRS groups; (E) CSE expression in Sham and DM-8w+CaRS+PAG groups. Notes: (A) CaSR expression in Sham group (a), DM-4w group (b), and DM-8w group (c). The quantitative analysis of CaSR expression is shown in “d”. Results are expressed as mean ± SD. (B) CSE expression in Sham group (a), DM-4w group (b), and DM-8w group (c). The quantitative analysis of CSE expression is shown in “d”. Results are expressed as mean ± SD. (C) CaSR expression in Sham group (a), DM-8w+CaRS group (b). The quantitative analysis of CaSR expression is shown in “c”. Results are expressed as mean ± SD. (D) CSE expression in Sham group (a) and DM-8w+CaRS group (b). The quantitative analysis of CSE expression is shown in “c”. Results are expressed as mean ± SD. (E) CSE expression in Sham group (a) and DM-8w+CaRS+PAG group (b). The quantitative analysis of CSE expression is shown in “c”. Results are expressed as mean ± SD. Magnification is ×100. A significant decrease from Sham group is denoted by *p<0.01, and a significant decrease from DW-4w group is denoted by **p<0.01. Abbreviations: CaSR, calcium-sensing receptor; DM, diabetes mellitus; CSE, cystathionine-γ-lyase; CaRS, calcium-sensing receptor stimulator; PAG, DL-propargylglycine.
Figure 7
Figure 7
(A) Histopathologic assessment of myocardial damage; (B) CaSR expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (C) CSE expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (D) H2S level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (E) [Ca2+]i level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (F) CaM expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups. Notes: (A) Light microscope images (×100) in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of histopathological assessment is shown in “i”. The histopathologic damage in DM-8w group is higher than that in Sham group (p<0.01), and the histopathologic damage in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is lower than that in DM-8w group (p<0.01); the histopathologic damage in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly lower than that in DM-8w group (p<0.01). (B) CaSR expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/ P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CaSR expression is shown in “B-i”. The CaSR expression in DM-8w group is lower than that in Sham group (p<0.01), and the CaSR expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (p<0.01); the CaSR expression in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (p<0.01). (C) CSE expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CSE expression is shown in “C-i”. The CSE expression in DM-8w group is lower than that in Sham group (p<0.01), and the CSE expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (p<0.01); the CSE expression in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (p<0.01). (D) The blood of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups were collected and the levels of H2S were measured. Results are expressed as mean ± SD. (E) The cardiac cells of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups were collected and the levels of [Ca2+]i were measured. Results are expressed as mean ± SD. (F) CaM expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CaM expression is shown in “i”. The CaM expression in DM-8w group is lower than that in Sham group (p<0.01), and the CaM expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (p<0.01); the CaM expression in Curcumin/P group, Curcumin/ P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (p<0.01). A significant decrease from Sham group is denoted by *p<0.01, a significant increase from DM-8w group is denoted by **p<0.01, and a significant increase from DM-8w group is denoted by ***p<0.01. Abbreviations: CaSR, calcium-sensing receptor; DM, diabetes mellitus; CSE, cystathionine-γ-lyase; CaRS, calcium-sensing receptor stimulator; CaRI, calcium-sensing receptor inhibitor; CaM, calmodulin; P, poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl l-glutamate); SD, standard deviation.
Figure 7
Figure 7
(A) Histopathologic assessment of myocardial damage; (B) CaSR expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (C) CSE expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (D) H2S level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (E) [Ca2+]i level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (F) CaM expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups. Notes: (A) Light microscope images (×100) in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of histopathological assessment is shown in “i”. The histopathologic damage in DM-8w group is higher than that in Sham group (p<0.01), and the histopathologic damage in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is lower than that in DM-8w group (p<0.01); the histopathologic damage in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly lower than that in DM-8w group (p<0.01). (B) CaSR expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/ P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CaSR expression is shown in “B-i”. The CaSR expression in DM-8w group is lower than that in Sham group (p<0.01), and the CaSR expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (p<0.01); the CaSR expression in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (p<0.01). (C) CSE expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CSE expression is shown in “C-i”. The CSE expression in DM-8w group is lower than that in Sham group (p<0.01), and the CSE expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (p<0.01); the CSE expression in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (p<0.01). (D) The blood of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups were collected and the levels of H2S were measured. Results are expressed as mean ± SD. (E) The cardiac cells of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups were collected and the levels of [Ca2+]i were measured. Results are expressed as mean ± SD. (F) CaM expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CaM expression is shown in “i”. The CaM expression in DM-8w group is lower than that in Sham group (p<0.01), and the CaM expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (p<0.01); the CaM expression in Curcumin/P group, Curcumin/ P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (p<0.01). A significant decrease from Sham group is denoted by *p<0.01, a significant increase from DM-8w group is denoted by **p<0.01, and a significant increase from DM-8w group is denoted by ***p<0.01. Abbreviations: CaSR, calcium-sensing receptor; DM, diabetes mellitus; CSE, cystathionine-γ-lyase; CaRS, calcium-sensing receptor stimulator; CaRI, calcium-sensing receptor inhibitor; CaM, calmodulin; P, poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl l-glutamate); SD, standard deviation.
Figure 7
Figure 7
(A) Histopathologic assessment of myocardial damage; (B) CaSR expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (C) CSE expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (D) H2S level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (E) [Ca2+]i level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (F) CaM expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups. Notes: (A) Light microscope images (×100) in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of histopathological assessment is shown in “i”. The histopathologic damage in DM-8w group is higher than that in Sham group (p<0.01), and the histopathologic damage in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is lower than that in DM-8w group (p<0.01); the histopathologic damage in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly lower than that in DM-8w group (p<0.01). (B) CaSR expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/ P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CaSR expression is shown in “B-i”. The CaSR expression in DM-8w group is lower than that in Sham group (p<0.01), and the CaSR expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (p<0.01); the CaSR expression in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (p<0.01). (C) CSE expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CSE expression is shown in “C-i”. The CSE expression in DM-8w group is lower than that in Sham group (p<0.01), and the CSE expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (p<0.01); the CSE expression in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (p<0.01). (D) The blood of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups were collected and the levels of H2S were measured. Results are expressed as mean ± SD. (E) The cardiac cells of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups were collected and the levels of [Ca2+]i were measured. Results are expressed as mean ± SD. (F) CaM expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CaM expression is shown in “i”. The CaM expression in DM-8w group is lower than that in Sham group (p<0.01), and the CaM expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (p<0.01); the CaM expression in Curcumin/P group, Curcumin/ P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (p<0.01). A significant decrease from Sham group is denoted by *p<0.01, a significant increase from DM-8w group is denoted by **p<0.01, and a significant increase from DM-8w group is denoted by ***p<0.01. Abbreviations: CaSR, calcium-sensing receptor; DM, diabetes mellitus; CSE, cystathionine-γ-lyase; CaRS, calcium-sensing receptor stimulator; CaRI, calcium-sensing receptor inhibitor; CaM, calmodulin; P, poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl l-glutamate); SD, standard deviation.
Figure 8
Figure 8
(A) Histopathologic assessment of myocardial damage; (B) H2S level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+ CaRS+PAG, and Curcumin/P+CaRS+PAG groups; (C) CSE expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/P+CaRS+PAG groups. Notes: (A) Light microscope images (×100) in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+PAG group (e), Curcumin/P+PAG group (f), Curcumin+CaRS+PAG group (g), and Curcumin/P+CaRS+PAG group (h). The quantitative analysis of histopathologic assessment is showed in “i”. The histopathologic damage in DM-8w group is higher than that in Sham group (p<0.01), and the histopathologic damage in Curcumin group, Curcumin+PAG group, and Curcumin+CaRS+PAG group is lower than that in Sham group (p<0.01); the histopathologic damage in Curcumin/P group, Curcumin/P+PAG group, and Curcumin/P+CaRS+PAG group is significantly lower than that in Sham group (p<0.01). (B) The blood of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/ P+CaRS+PAG groups were collected and the levels of H2S were measured. Results are expressed as mean ± SD. (C) The cardiac tissues of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/P+CaRS+PAG groups and the expression of CSE were measured. Results are expressed as mean ± SD. A significant decrease from Sham group is denoted by *p<0.01, a significant increase from DM-8w group is denoted by **p<0.01, and a significant increase from DM-8w group is denoted by ***p<0.01. Abbreviations: CaSR, calcium-sensing receptor; DM, diabetes mellitus; CSE, cystathionine-γ-lyase; CaRS, calcium-sensing receptor stimulator; PAG, DL-propargylglycine; CaM, calmodulin; P, poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl l-glutamate); SD, standard deviation.
Figure 9
Figure 9
(A) Apoptosis assessment of cardiac cells in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups. (B) Apoptosis assessment of cardiac cell in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/ P+CaRS+PAG groups. Notes: (A) Apoptosis in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The apoptosis in DM-8w group is higher than that in Sham group, and the apoptosis in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is lower than that in DM-8w group; the apoptosis in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly lower than that in DM-8w group. (B) Apoptosis in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+PAG group (e), Curcumin/P+PAG group (f), Curcumin+CaRS+PAG group (g), and Curcumin/P+CaRS+PAG group (h). The apoptosis in DM-8w group is higher than that in Sham group, and the apoptosis in Curcumin group, Curcumin+PAG group, and Curcumin+CaRS+PAG group is lower than that in DM-8w group; the apoptosis in Curcumin/P group, Curcumin/P+PAG group, and Curcumin/P+CaRS+PAG group is significantly lower than that in DM-8w group. Magnification is ×100. Abbreviations: CaSR, calcium sensing receptor; DM, diabetes mellitus; CaRS, calcium-sensing receptor stimulator; CaRI, calcium-sensing receptor inhibitor; P, poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl l-glutamate); PAG, DL-propargylglycine.
Scheme 1
Scheme 1
Encapsulation of curcumin by PBLG-PEG-PBLG (P). Abbreviation: P, poly(gamma-benzyl l-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl l-glutamate).

Similar articles

Cited by

References

    1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431. - PubMed
    1. Yu W, Wu J, Cai F, et al. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. PLoS One. 2012;7:e52013. - PMC - PubMed
    1. Mano Y, Anzai T, Kaneko H, et al. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy. Circ J. 2011;75:1717–1727. - PubMed
    1. Wang J, Wang H, Hao P, et al. Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats. Mol Med. 2011;17:172–179. - PMC - PubMed
    1. Zhou H, Li YJ, Wang M, et al. Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes. Acta Pharmacol Sin. 2011;32:999–1008. - PMC - PubMed

Publication types

MeSH terms